Allison Conravey
Neurology with Special Qualifications in Child Neurology · New Orleans, LANPI 1962693184
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $9,165 of the $14,832 with a category attached, or 61.8%. 26 manufacturers reported payments, led by UCB, Inc. at 49.1% of the total. Reporting peaked in 2024 at $6,606 and has fallen 71.3% since, to $1,894 in 2025.
Across 215 payments — averaging $68.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- UCB, Inc.$7K
- DIXI Medical USA Corp$2K
- Livanova USA, Inc.$1K
- Jazz Pharmaceuticals Inc.$1K
- Neurelis, Inc.$454
- SK Life Science, Inc.$432
- plus $2K from 20 others
What the payments were for
- Consulting fees$3,60024%
- Travel & lodging$2,05514%
- Food & beverage$9,16562%
- Education$130%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| UCB, Inc. | 62 | $7,277 |
| DIXI Medical USA Corp | 3 | $1,814 |
| Livanova USA, Inc. | 12 | $1,484 |
| Jazz Pharmaceuticals Inc. | 40 | $1,473 |
| Neurelis, Inc. | 7 | $454 |
| SK Life Science, Inc. | 8 | $432 |
| Sunovion Pharmaceuticals Inc. | 14 | $353 |
| Supernus Pharmaceuticals, Inc. | 21 | $226 |
| Greenwich Biosciences, Inc. | 4 | $207 |
| Biocodex, Inc. | 4 | $170 |
| Sarepta Therapeutics, Inc. | 5 | $150 |
| PTC Therapeutics, Inc. | 6 | $138 |
| Biogen | 5 | $115 |
| Eisai Inc. | 4 | $73 |
| Zevra Therapeutics Inc | 1 | $72 |
| Azurity Pharmaceuticals, Inc. | 3 | $58 |
| Sanofi | 2 | $53 |
| Aucta Pharmaceuticals, Inc. | 2 | $49 |
| Acadia Pharmaceuticals Inc | 2 | $47 |
| Genentech USA, Inc. | 2 | $44 |
| Zogenix Inc. | 2 | $44 |
| Immedica Pharma US, Inc. | 2 | $34 |
| Upsher-smith Laboratories LLC | 1 | $27 |
| NS Pharma, Inc. | 1 | $17 |
| Biomarin Pharmaceutical Inc. | 1 | $17 |
| Sumitomo Pharma America, Inc. | 1 | $4 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$14,832 in reported general payments places this provider in the 85th percentile of 30 neurology with special qualifications in child neurology providers in Louisiana.
See all neurology with special qualifications in child neurology providers in Louisiana →
Other neurology with special qualifications in child neurology in New Orleans
- Ann Henderson TiltonNew Orleans$119K
- Joaquin WongNew Orleans$28K
- David HoughtonNew Orleans$9K
- Jeremy TolerNew Orleans$9K
- Jessica GautreauxNew Orleans$9K
- Daniella MillerNew Orleans$8K
- Maria WeimerNew Orleans$6K
- Rashmi RaoNew Orleans$5K
- Kelly AngelleNew Orleans$3K
- Kayla PenceNew Orleans$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.